Thrilled to receive a Recognition Award from Doctoral Researcher Awards #DRA2022 for my work at the intersection of tumor immunology and Next-gen genomics. 'Two distinct functional phenotypes in regulatory T cells drives immune suppression in pancreatic cancer ' University of Oxford #NatLifeSci

Have you wondered what are the key factors that determine immune evasion in pancreatic ductal adenocarcinoma (PDAC)? We show that the divergent tumour microenvironments between patients exhibit distinct key immunosuppressive mechanisms. Our new preprint biorxiv.org/content/10.110…

Incredibly happy, but not at all surprised, for my best friend Ashwin Jainarayanan (also Y Combinator Granza Bio (YC W24) cofounder) being named 2024 Schmidt Science Fellows among 32 others! So proud, excited for you, Ashwin!🎉 ox.ac.uk/news/2024-05-0… University of Oxford Kennedy Institute of Rheumatology #schmidtsciencefellow

Dr Ashwin Jainarayanan selected for 2024 Schmidt Science Fellow program | University of Oxford ox.ac.uk/news/2024-05-0… I'm so happy for Ashwin! His achievement is very well-deserved, and it's a testament to his incredible hard work. Mentoring him was a great experience. I look

Dr Ashwin Jainarayanan has been selected to become a 2024 Schmidt Science Fellow – an honour bestowed on only 32 exceptional early career researchers worldwide. Congratulations, Dr Jainarayanan 👏 ox.ac.uk/news/2024-05-0…

Excited to share our new study on the heterogeneity of interstitial macrophages based on their chemokine expression -conserved in humans and mice- a major role is to orchestrate leukocyte recruitment and establish TLS formation. Xin Li Arlind Mara nature.com/articles/s4159…

RIFINs displayed on malaria-infected erythrocytes bind both KIR2DL1 and KIR2DS1 biorxiv.org/content/10.110…

Gliobastomas are among the most aggressive and fatal cancers. After marked success treating 10 dogs, a unique IV "onionized" mRNA/nanoparticle individualized vaccine induced a striking anti-tumor immune response cell.com/cell/abstract/… Cell FLORIDA

It's a true honor to join the Schmidt Science Fellows community of early-career scientists dedicated to pioneering interdisciplinary science 🧬✨! I look forward to connecting with everyone involved and making the most of this incredible experience 🙏💫 forbes.com/sites/michaelt…

Big thanks to the Kennedy Institute of Rheumatology, NDORMS, and especially the Michael Dustin lab, for their unwavering support and guidance. 🙏 Reflecting on my time here, I'm filled with gratitude for the opportunities and nurturing environment.🌱🌟

Don´t miss this Review summarizing the different antibody-based approaches for targeting cancer cells including #CheckpointInhibitors, bispecific antibodies and #AntibodyDrugConjugates, as well as strategies that improve efficacy and reduce toxicities. go.nature.com/3wWetGE

Damn beautiful paper. Hats off to this amazing work!

Cellular architecture is a predeterminant of early TCR signaling and subsequent cell fate decisions of individual naïve T cells in response to antigen Science Magazine Ben Hale Berend Snijder science.org/doi/10.1126/sc…

Delighted to share that Granza Bio (YC W24) (YC W24) has secured a $7.14M seed round led by Felicis and Refactor! Transforming how we deliver therapeutic cargo to target tissues. Stay tuned for more! 🚀 Read more: shorturl.at/cXn6Z Michael Dustin | Ashwin Nandakumar, DPhil | Granza Bio (YC W24)

Congrats to the Granza Bio (YC W24) team on the $7.14M Seed! Founded by Ashwin Nandakumar, DPhil, Ashwin Jainarayanan, and Michael Dustin, Granza Bio (YC W24) is working to advance the delivery of cancer treatments and genetic medicine to specific tissue sites in our body. techcrunch.com/2024/07/03/gra…

Synaptic synergy of T cell receptor and interleukin 2 receptor in CD8+ T cells biorxiv.org/content/10.110…

I'm thrilled to announce that my paper in redox biology is finally out! This milestone marks my first solo corresponding author publication, a significant achievement i'm proud to share. Seeing the final product is surreal, and I'm grateful to share this moment with you. (1/6)

Our BS-MS 2014 alumnus Dr. Ashwin Kumar Jainarayanan, Cofounder, Granza Bio features in Forbes Europe Science & Healthcare (2025) 30 under 30 list! Truly remarkable. Congratulations Ashwin! forbes.com/profile/ashwin… Ashwin Jainarayanan

Dr Ashwin Jainarayanan (Ashwin Jainarayanan) completed his DPhil last year in Prof Mike Dustin's lab and then co-founded Granza Bio. He has been named in the Forbes 30 Under 30 list for Science and Healthcare in Europe 2025! Congratulations, Ashwin!! 🎉 kennedy.ox.ac.uk/news/dr-ashwin…

Indian Institute of Science Education and Research Mohali (IISER Mohali) At IISER Mohali, science evolves through global partnerships, innovative ideas, and a strong research culture. •i-RISE: Innovation Rises Here IISER Mohali has a Technology Business Incubator called